173 related articles for article (PubMed ID: 22470805)
1. Retroperitoneal fibrosis as a cause of positive FDG PET/CT.
Mehta A; Blodgett TM
J Radiol Case Rep; 2011; 5(7):35-41. PubMed ID: 22470805
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
[TBL] [Abstract][Full Text] [Related]
3. Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG).
Kotani S; Wakamatsu R; Itoh A; Miyamoto K; Yoshino M; Takami K; Ishihara S; Miura N; Banno S; Imai H
Intern Med; 2012; 51(7):755-8. PubMed ID: 22466833
[TBL] [Abstract][Full Text] [Related]
4. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
[TBL] [Abstract][Full Text] [Related]
5. Secondary retroperitoneal fibrosis due to polyarteritis nodosa evaluated by F-18 FDG PET/CT.
Taniguchi Y; Kumon Y; Kagawa T; Terada Y
Clin Nucl Med; 2011 Nov; 36(11):1044-5. PubMed ID: 21975401
[No Abstract] [Full Text] [Related]
6. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review.
Treglia G; Mattoli MV; Bertagna F; Giubbini R; Giordano A
Rheumatol Int; 2013 Mar; 33(3):549-55. PubMed ID: 23124736
[TBL] [Abstract][Full Text] [Related]
7. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
Moroni G; Castellani M; Balzani A; Dore R; Bonelli N; Longhi S; Martinelli I; Messa P; Gerundini P
Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1635-42. PubMed ID: 22801728
[TBL] [Abstract][Full Text] [Related]
8. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
Young PM; Peterson JJ; Calamia KT
Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis.
Otsuka H; Morita N; Yamashita K; Nishitani H
Ann Nucl Med; 2007 Dec; 21(10):593-6. PubMed ID: 18092136
[TBL] [Abstract][Full Text] [Related]
10. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.
Bertagna F; Treglia G; Leccisotti L; Bosio G; Motta F; Giordano A; Giubbini R
Jpn J Radiol; 2012 Jun; 30(5):415-21. PubMed ID: 22421932
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?
Guignard R; Simukoniene M; Garibotto V; Ratib O
Clin Nucl Med; 2012 May; 37(5):453-9. PubMed ID: 22475894
[TBL] [Abstract][Full Text] [Related]
12. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT appearance of tumor thrombus of ovarian vessels masquerading as retroperitoneal fibrosis.
Luo Y; Feng R; Li F
Clin Nucl Med; 2015 Jun; 40(6):501-3. PubMed ID: 25546209
[TBL] [Abstract][Full Text] [Related]
14. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
Nemec P; Rehák Z; Fabián P; Soucek M
Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm.
Wiggermann P; Aust D; Stroszczynski C; Kotzerke J; Zöphel K
Nuklearmedizin; 2011; 50(3):N21-2. PubMed ID: 21611677
[No Abstract] [Full Text] [Related]
16. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic Retroperitoneal Fibrosis With Intense Uptake of 68Ga-Fibroblast Activation Protein Inhibitor and 18F-FDG.
Pan Q; Luo Y; Zhang W
Clin Nucl Med; 2021 Feb; 46(2):175-176. PubMed ID: 33208623
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
19. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
Pipitone N; Versari A; Vaglio A; Salvarani C
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
[TBL] [Abstract][Full Text] [Related]
20. The value of
Wang Y; Guan Z; Gao D; Luo G; Li K; Zhao Y; Wang X; Zhang J; Jin J; Zhao Z; Yang C; Zhang J; Zhu J; Huang F
Semin Arthritis Rheum; 2018 Feb; 47(4):593-600. PubMed ID: 28958769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
